HER2 is a member of the epidermal growth factor receptor (EGFR) family with tyrosine kinase catalytic activity and is implicated in a variety of cancers with epithelial origin such as bladder, breast, ovarian, cervical, uterine, prostate, lung, kidney and colorectal cancer [6]. Here, ERBB2 is linked to cancer.